|
1
|
Bast RC Jr, Hennessy B and Mills GB: The
biology of ovarian cancer: New opportunities for translation. Nat
Rev Cancer. 9:415–428. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Masoumi-Moghaddam S, Amini A, Wei AQ,
Robertson G and Morris DL: Vascular endothelial growth factor
expression correlates with serum CA125 and represents a useful tool
in prediction of refractoriness to platinum-based chemotherapy and
ascites formation in epithelial ovarian cancer. Oncotarget.
6:28491–28501. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagaraj AB, Joseph P, Kovalenko O, Singh
S, Armstrong A, Redline R, Resnick K, Zanotti K, Waggoner S and
DiFeo A: Critical role of Wnt/β-catenin signaling in driving
epithelial ovarian cancer platinum resistance. Oncotarget.
6:23720–23734. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Prislei S, Martinelli E, Zannoni GF,
Petrillo M, Filippetti F, Mariani M, Mozzetti S, Raspaglio G,
Scambia G and Ferlini C: Role and prognostic significance of the
epithelial-mesenchymal transition factor ZEB2 in ovarian cancer.
Oncotarget. 6:18966–18979. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu YH, Chang TH, Huang YF, Chen CC and
Chou CY: COL11A1 confers chemoresistance on ovarian cancer cells
through the activation of Akt/c/EBPβ pathway and PDK1
stabilization. Oncotarget. 6:23748–23763. 2015.PubMed/NCBI
|
|
7
|
Zeng R, Zhang R, Song X, Ni L, Lai Z, Liu
C and Ye W: The long non-coding RNA MALAT1 activates Nrf2 signaling
to protect human umbilical vein endothelial cells from hydrogen
peroxide. Biochem Biophys Res Commun. 495:2532–2538. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cho HY, Kim K, Jeon YT, Kim YB and No JH:
CA19-9 elevation in ovarian mature cystic teratoma: Discrimination
from ovarian cancer-CA19-9 level in teratoma. Med Sci Monit.
19:230–235. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barger CJ, Zhang W, Hillman J, Stablewski
AB, Higgins MJ, Vanderhyden BC, Odunsi K and Karpf AR: Genetic
determinants of FOXM1 overexpression in epithelial ovarian cancer
and functional contribution to cell cycle progression. Oncotarget.
6:27613–27627. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu S, Fu GB, Tao Z, OuYang J, Kong F,
Jiang BH, Wan X and Chen K: MiR-497 decreases cisplatin resistance
in ovarian cancer cells by targeting mTOR/P70S6K1. Oncotarget.
6:26457–26471. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rustin G, van der Burg M, Griffin C, Qian
W and Swart AM: Early versus delayed treatment of relapsed ovarian
cancer. Lancet. 377:380–381. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yao M, Niu G, Sheng Z, Wang Z and Fei J:
Identification of a Smad4/YY1-recognized and BMP2-responsive
transcriptional regulatory module in the promoter of mouse GABA
transporter subtype I (Gat1) gene. J Neurosci. 30:4062–4071. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim KR, Oh SY, Park UC, Wang JH, Lee JD,
Kweon HJ, Kim SY, Park SH, Choi DK, Kim CG, et al: Gene expression
profiling using oligonucleotide microarray in atrophic gastritis
and intestinal metaplasia. Korean J Gastroenterol. 49:209–224.
2007.(In Korean). PubMed/NCBI
|
|
14
|
Maolakuerban N, Azhati B, Tusong H, Abula
A, Yasheng A and Xireyazidan A: MiR-200c-3p inhibits cell migration
and invasion of clear cell renal cell carcinoma via regulating
SLC6A1. Cancer Biol Ther. 19:282–291. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lei W, Kang W, Nan Y, Lei Z, Zhongdong L,
Demin L, Lei S and Hairong H: The downregulation of miR-200c
promotes lactate dehydrogenase A expression and non-small cell lung
cancer progression. Oncol Res. Jan 10–2018.(Epub ahead of print).
View Article : Google Scholar
|
|
16
|
Zhou X, Men X, Zhao R, Han J, Fan Z, Wang
Y, Lv Y, Zuo J, Zhao L, Sang M, et al: miR-200c inhibits
TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting
ZEB1 and ZEB2 in gastric cancer. Cancer Gene Ther. 25:68–76. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
De Falco M, Fedele V, Cobellis L,
Mastrogiacomo A, Giraldi D, Leone S, De Luca L, Laforgia V and De
Luca A: Pattern of expression of cyclin D1/CDK4 complex in human
placenta during gestation. Cell Tissue Res. 317:187–194. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu X, Zhao W, Yang X, Wang Z and Hao M:
miR-375 affects the proliferation, invasion, and apoptosis of
HPV16-positive human cervical cancer cells by targeting IGF-1R. Int
J Gynecol Cancer. 26:851–858. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu Y, Arora A, Min W, Roifman CM and
Grunebaum E: EdU incorporation is an alternative non-radioactive
assay to [3H]thymidine uptake for in vitro measurement
of mice T-cell proliferations. J Immunol Methods. 350:29–35. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He HJ, Zhu TN, Xie Y, Fan J, Kole S,
Saxena S and Bernier M: Pyrrolidine dithiocarbamate inhibits
interleukin-6 signaling through impaired STAT3 activation and
association with transcriptional coactivators in hepatocytes. J
Biol Chem. 281:31369–31379. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu LJ, Yu MH, Huang CY, Niu LX, Wang YF,
Wu CZ, Yang PM and Hu X: Isoprenylated flavonoids from Morus nigra
and their PPAR γ agonistic activities. Fitoterapia. 127:109–114.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Iglesias-Ara A, Osinalde N and Zubiaga AM:
Detection of E2F-induced transcriptional activity using a dual
luciferase reporter assay. Methods Mol Biol. 1726:153–166. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tarnow P, Bross S, Wollenberg L, Nakajima
Y, Ohmiya Y, Tralau T and Luch A: A novel dual-color luciferase
reporter assay for simultaneous detection of estrogen and aryl
hydrocarbon receptor activation. Chem Res Toxicol. 30:1436–1447.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao J, Tao J, Zhang N, Liu Y, Jiang M, Hou
Y, Wang Q and Bai G: Formula optimization of the Jiashitang scar
removal ointment and antiinflammatory compounds screening by NF-κB
bioactivity-guided dual-luciferase reporter assay system. Phytother
Res. 29:241–250. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu X and Wu X: Utilizing Matrigel
Transwell invasion assay to detect and enumerate circulating tumor
cells. Methods Mol Biol. 1634:277–282. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lai H, Zhao X, Qin Y, Ding Y, Chen R, Li
G, Labrie M, Ding Z, Zhou J, Hu J, et al: FAK-ERK activation in
cell/matrix adhesion induced by the loss of apolipoprotein E
stimulates the malignant progression of ovarian cancer. J Exp Clin
Cancer Res. 37:322018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi W, Wang X, Ruan L, Fu J, Liu F and Qu
J: MiR-200a promotes epithelial-mesenchymal transition of
endometrial cancer cells by negatively regulating FOXA2 expression.
Pharmazie. 72:694–699. 2017.PubMed/NCBI
|
|
29
|
Zhao H, Qin X, Zhang Q, Zhang X, Lin J,
Ting K and Chen F: Nell-1-ΔE, a novel transcript of Nell-1,
inhibits cell migration by interacting with enolase-1. J Cell
Biochem. 119:5725–5733. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tong J and Wang Z: Analysis of epidermal
growth factor receptor-induced cell motility by wound healing
assay. Methods Mol Biol. 1652:159–163. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bedoya C, Cardona A, Galeano J,
Cortés-Mancera F, Sandoz P and Zarzycki A: Accurate
region-of-interest recovery improves the measurement of the cell
migration rate in the in vitro wound healing assay. SLAS Technol.
22:626–635. 2017.PubMed/NCBI
|
|
32
|
Riis S, Newman R, Ipek H, Andersen JI,
Kuninger D, Boucher S, Vemuri MC, Pennisi CP, Zachar V and Fink T:
Hypoxia enhances the wound-healing potential of adipose-derived
stem cells in a novel human primary keratinocyte-based scratch
assay. Int J Mol Med. 39:587–594. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Beck F: The role of Cdx genes in the
mammalian gut. Gut. 53:1394–1396. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mizoshita T, Inada K, Tsukamoto T, Kodera
Y, Yamamura Y, Hirai T, Kato T, Joh T, Itoh M and Tatematsu M:
Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression
to differentiation in human gastrointestinal mucosa - with special
emphasis on participation in intestinal metaplasia of the human
stomach. Gastric Cancer. 4:185–191. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Suh E, Chen L, Taylor J and Traber PG: A
homeodomain protein related to caudal regulates intestine-specific
gene transcription. Mol Cell Biol. 14:7340–7351. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bai YQ, Miyake S, Iwai T and Yuasa Y:
CDX2, a homeobox transcription factor, upregulates transcription of
the p21/WAF1/CIP1 gene. Oncogene. 22:7942–7949. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Raymond A, Liu B, Liang H, Wei C, Guindani
M, Lu Y, Liang S, St John LS, Molldrem J and Nagarajan L: A role
for BMP-induced homeobox gene MIXL1 in acute myelogenous leukemia
and identification of type I BMP receptor as a potential target for
therapy. Oncotarget. 5:12675–12693. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rouhi A and Fröhling S: Deregulation of
the CDX2-KLF4 axis in acute myeloid leukemia and colon cancer.
Oncotarget. 4:174–175. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yan LH, Wei WY, Xie YB and Xiao Q: New
insights into the functions and localization of the homeotic gene
CDX2 in gastric cancer. World J Gastroenterol. 20:3960–3966. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Camilo V, Barros R, Celestino R, Castro P,
Vieira J, Teixeira MR, Carneiro F, Pinto-de-Sousa J, David L and
Almeida R: Immunohistochemical molecular phenotypes of gastric
cancer based on SOX2 and CDX2 predict patient outcome. BMC Cancer.
14:7532014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Camilo V, Garrido M, Valente P, Ricardo S,
Amaral AL, Barros R, Chaves P, Carneiro F, David L and Almeida R:
Differentiation reprogramming in gastric intestinal metaplasia and
dysplasia: Role of SOX2 and CDX2. Histopathology. 66:343–350. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Schildberg CW, Abba M, Merkel S, Agaimy A,
Dimmler A, Schlabrakowski A, Croner R, Leupold JH, Hohenberger W
and Allgayer H: Gastric cancer patients less than 50 years of age
exhibit significant downregulation of E-cadherin and CDX2 compared
to older reference populations. Adv Med Sci. 59:142–146. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cobler L, Pera M, Garrido M, Iglesias M
and de Bolós C: CDX2 can be regulated through the signalling
pathways activated by IL-6 in gastric cells. Biochim Biophys Acta.
1839:785–792. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang J, Li T, Gao C, Lv X, Liu K, Song H,
Xing Y and Xi T: FOXO1 3′UTR functions as a ceRNA in repressing the
metastases of breast cancer cells via regulating miRNA activity.
FEBS Lett. 588:3218–3224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF, et al: The lncRNA H19
promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kumar MS, Armenteros-Monterroso E, East P,
Chakravorty P, Matthews N, Winslow MM and Downward J: HMGA2
functions as a competing endogenous RNA to promote lung cancer
progression. Nature. 505:212–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Karreth FA, Tay Y, Perna D, Ala U, Tan SM,
Rust AG, DeNicola G, Webster KA, Weiss D, Perez-Mancera PA, et al:
In vivo identification of tumor-suppressive PTEN ceRNAs in an
oncogenic BRAF-induced mouse model of melanoma. Cell. 147:382–395.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Karreth FA, Reschke M, Ruocco A, Ng C,
Chapuy B, Léopold V, Sjoberg M, Keane TM, Verma A, Ala U, et al:
The BRAF pseudogene functions as a competitive endogenous RNA and
induces lymphoma in vivo. Cell. 161:319–332. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Esposito F, De Martino M, D'Angelo D,
Mussnich P, Raverot G, Jaffrain-Rea ML, Fraggetta F, Trouillas J
and Fusco A: HMGA1-pseudogene expression is induced in human
pituitary tumors. Cell Cycle. 14:1471–1475. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Poliseno L and Pandolfi PP: PTEN ceRNA
networks in human cancer. Methods. 77-78:1–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Shen J, Hu Q, Schrauder M, Yan L, Wang D,
Medico L, Guo Y, Yao S, Zhu Q, Liu B, et al: Circulating miR-148b
and miR-133a as biomarkers for breast cancer detection. Oncotarget.
5:5284–5294. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Nohata N, Hanazawa T, Enokida H and Seki
N: microRNA-1/133a and microRNA-206/133b clusters: Dysregulation
and functional roles in human cancers. Oncotarget. 3:9–21. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Luo J, Zhou J, Cheng Q, Zhou C and Ding Z:
Role of microRNA-133a in epithelial ovarian cancer pathogenesis and
progression. Oncol Lett. 7:1043–1048. 2014. View Article : Google Scholar : PubMed/NCBI
|
